Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Feb 16, 2012

30016_dirs_2012-02-16_3cd7cfbf-ab89-40b2-9f57-bff61a85c63a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14

Reporting Person: DEADY CONAN R (CORP VP, GENERAL COUNSEL & SEC)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common Stock M 258 Acquired 15820 Direct
2012-02-14 Common Stock M 375 Acquired 16195 Direct
2012-02-14 Common Stock M 364 Acquired 16559 Direct
2012-02-14 Common Stock M 300 Acquired 16859 Direct
2012-02-14 Common Stock M 476 Acquired 17335 Direct
2012-02-14 Common Stock F 591 $87.42 Disposed 16744 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Non-Qualified Stock Option (right to buy) $87.42 A 10951 Acquired 2019-02-13 Common Stock (10951) Direct
2012-02-14 Incentive Stock Option (right to buy) $87.42 A 1143 Acquired 2019-02-13 Common Stock (1143) Direct
2012-02-14 Restricted Stock Unit $ A 1215 Acquired Common Stock (1215) Direct
2012-02-14 Restricted Stock Unit $ M 258 Disposed Common Stock (258) Direct
2012-02-14 Restricted Stock Unit $ M 375 Disposed Common Stock (375) Direct
2012-02-14 Restricted Stock Unit $ M 364 Disposed Common Stock (364) Direct
2012-02-14 Restricted Stock Unit $ M 300 Disposed Common Stock (300) Direct
2012-02-14 Restricted Stock Unit $ M 476 Disposed Common Stock (476) Direct

Footnotes

F1: Grant of options to buy shares of common stock becomes exercisable as to 2,419 shares on 02/14/2013, 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 1,275 shares on 02/14/2017.

F2: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.

F3: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.